CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative DiseaseConstanze Slabik, Renata Stripecke|Molecular Therapy — Oncolytics|2020Cited by 77
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc García-Moure, Marta M. Alonso, Eric H. Raabe et al.|Clinical Cancer Research|2020Cited by 25
Supp Figure 2 from Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc García-Moure, Marta M. Alonso, Marisol González-Huarriz et al.|Unknown|2023Cited by 0
Supp Figure 1 from Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc García-Moure, Marta M. Alonso, Eric H. Raabe et al.|Unknown|2023Cited by 0
Supp Figure 4 from Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc García-Moure, Marta M. Alonso, Marisol González-Huarriz et al.|Unknown|2023Cited by 0